Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 80 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,827.50
Market cap: ₹1,06,141 Cr
Revenue (annual): ₹33,653 Cr
Net profit (annual): ₹3,505 Cr
P/E (TTM): 25.2×Sector 43.8×
Promoter holding: 51.88%+0.00% QoQ
FII holding: 17.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 2 Results Update 1 Other Announcement 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Earnings Call 1 Dividend 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Nov 2026 20:31 IST NSE

Merger & Restructuring

Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr

Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.

Value: ₹29.00 Cr
Execution: 60-90 days

Open announcement → Read the filing ↗